Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Tokyo  >  ONO PHARMACEUTICAL CO., LTD.    4528   JP3197600004

 SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Financials ( JPY)
Sales 2017 250 398 M
EBIT 2017 -
Net income 2017 53 292 M
Finance 2017 124 853 M
Yield 2017 1,67%
Sales 2018 256 464 M
EBIT 2018 -
Net income 2018 50 873 M
Finance 2018 146 585 M
Yield 2018 1,77%
P/E ratio 2017 25,20
P/E ratio 2018 27,08
EV / Sales2017 5,44x
EV / Sales2018 5,22x
Capitalization 1 486 057 M
More Financials
Company
Ono Pharmaceutical Co., Ltd. engages in the production, purchase, and sale of pharmaceutical and diagnostic reagents focusing on prescription pharmaceuticals.Its products include respiratory, digestive, urinary, chemotherapy, hormone, vitamins, and metabolic drugs.The company was founded by Ichibei... 
More about the company
Surperformance© ratings of ONO PHARMACEUTICAL CO., LT
Trading Rating : Investor Rating :
More Ratings
Latest news on ONO PHARMACEUTICAL CO., LT
02/15 LAUNCH OF PARSABIV® INTRAVENOUS INJE : Etelcalcetide Hydrochloride), a Calcimime..
02/08 ONO PHARMACEUTICAL : U.S. Food and Drug Administration Approves Parsabiv™ ..
02/06 ONO PHARMACEUTICAL : Certain Media Coverage Related to ONO Reported on February ..
02/03 ONO PHARMACEUTICAL : Bristol-Myers Squibb Receives FDA Approval for Opdivo (nivo..
02/02 Bristol-Myers Squibb and Ono Pharmaceutical Company Enter Settlement and Lice..
01/24 BRISTOL-MYERS SQUIBB CO (NYSE : BMY) To Share In Sales Of Merck & Co., Inc. (NYS..
01/21 ONO PHARMACEUTICAL : and Bristol-Myers Squibb Enter Settlement and License Agree..
01/20 ONO PHARMACEUTICAL : Bristol-Myers Squibb Provides Regulatory Update in First-li..
01/20 ONO PHARMACEUTICAL : Data with OPDIVO® (nivolumab) Intravenous Infusion in Gastr..
2016 ONO PHARMACEUTICAL : Submits Supplemental Application of OPDIVO® (Nivolumab) for..
More news
Sector news : Generic Pharmaceuticals
12:59a Exclusive - Trump says Republican border tax could boost U.S. jobs
02/23DJPFIZER : Files 8K - Changes Executive Management
02/23DJGlaxoSmithKline Reports Positive Study Results for Asthma Drug
02/23DJPURETECH HEALTH : Appoints Atul Pande as Chief Medical Officer
02/23DJBAYER : Financing Plan Will Raise Equity First Then Bonds -- WSJ
More sector news : Generic Pharmaceuticals
Latest Tweets
02/06ONO PHARMACEUTICAL : Certain Media Coverage Related to ONO Reported on Februa.. 
01/20BRIEF-Bristol-Myers squibb and Ono pharmaceutical enters license agreement wi.. 
2016BRIEF-Ligand enters into worldwide OmniAb platform license agreement with ONO.. 
2016Ligand Pharmaceuticals : Enters into Worldwide OmniAb® Platform License Agree.. 
2016ONO PHARMACEUTICAL : Revisions of Consolidated Financial Forecasts (86.8KB) .. 
More tweets
Qtime:26
News from SeekingAlpha
01/23 Bristol Catches A Break At Last
2016 Opdivo's price halved in Japan
2016 Bristol's Bid To Get Ahead In Head And Neck
2016 A European Biotech Stock Basket For 2016 - Update
Advertisement
Chart ONO PHARMACEUTICAL CO., LT
Duration : Period :
ONO PHARMACEUTICAL CO., LT Technical Analysis Chart | 4528 | JP3197600004 | 4-Traders
Full-screen chart
Technical analysis trends ONO PHARMACEUTICA...
Short TermMid-TermLong Term
TrendsBullishBearishBearish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 13
Average target price 3 053  JPY
Spread / Average Target 21%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Gyo Sagara President & Representative Director
Shozo Matsuoka Executive Officer & Manager-Medical Affairs
Kazuhito Kawabata Director & Managing Executive Officer
Hiroshi Awata Director, EVP & General Manager-Development
Isao Ono Director & Managing Executive Officer
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
ONO PHARMACEUTICAL CO...-1.43%13 172
OTSUKA HOLDINGS CO LTD1.79%25 633
SUN PHARMACEUTICAL IND..6.41%24 280
ASPEN PHARMACARE HOLDI..0.93%10 145
SHANGHAI FOSUN PHARMAC..11.11%9 052
TAISHO PHARMACEUTICAL ..-3.91%7 455
More Results